CELLPROTHERA
Live / Registered — International registration cancelled — extension of protection cancelled (as of 01 Aug 2019)
What this means for you
Registered since 21 Jun 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79076423
- Registration number
- 3980163
- Mark type
- Design + words
- Filed
- 31 Jul 2009
- Published for opposition
- 05 Apr 2011
- Registered
- 21 Jun 2011
- Attorney of record
- Jonathan Myers
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical use
- Class 010 — Medical apparatus: Medical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatment
- Class 042 — Scientific and technological services: Research and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third parties
- Class 044 — Medical, beauty and agricultural services: Medical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicine
Owner
- CELLPROTHERA, FR
- CELLPROTHERA, FR
- CELLPROTHERA, FR
Prosecution history
- 30 May 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Oct 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 04 Sept 2021 — NOTIFICATION PROCESSED BY IB
- 29 Aug 2020 — REFUSAL PROCESSED BY IB
- 21 Feb 2020 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 21 Feb 2020 — DEATH OF INTERNATIONAL REGISTRATION
- 22 Aug 2019 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 01 Aug 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Dec 2018 — TOTAL INVALIDATION PROCESSED BY THE IB
- 27 Sept 2018 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 27 Sept 2018 — INVALIDATION PROCESSED
- 26 Sept 2018 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Jan 2018 — CANCELLED SECTION 71
- 14 May 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 17 Nov 2011 — FINAL DISPOSITION NOTICE SENT TO IB